CMAJ • October 26, 2004; 171 (9). doi:10.1503/cmaj.1041115.
© 2004 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kherani, R. B.
Right arrow Articles by Fung, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kherani, R. B.
Right arrow Articles by Fung, M.

Letters
Correspondance

To self-cite or not to self-cite

Raheem B. Kherani* and Michelle Fung{dagger}

*Rheumatology Fellow, University of British Columbia, Vancouver, BC; {dagger}University of British Columbia, Vancouver, BC

The article by Apoor Gami and associates1 on self-citation in the diabetes literature included 1 self-citation (out of a total of 9 references), which involved 3 of the study's authors (reference 6 in the original article). Thus, self-citation constituted 11% of the article's citations, which is more than the reported mean of 18% and median of 7%.

We agree that this phenomenon is prevalent in the literature. We, too, have published articles with self-citations.2,3 In fact, this letter now has a self-citation rate of 66%!

Raheem B. Kherani Rheumatology Fellow Michelle Fung University of British Columbia Vancouver, BC

References

  1. Gami AS, Montori VM, Wilczynski NL, Haynes RB. Author self-citation in the diabetes literature. CMAJ 2004;170(13):1925-7. [Abstract/Free Full Text]
  2. Kherani RB, Papaioannou A, Adachi JD. Long-term tolerability of the bisphosphonates in postmenopausal osteoporosis: a comparative review. Drug Saf 2002;25(11):781-90. [CrossRef][Medline]
  3. Fung MA, Frohlich JJ. Common problems in the management of hypertriglyceridemia. CMAJ 2002; 167(11):1261-6. [Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kherani, R. B.
Right arrow Articles by Fung, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kherani, R. B.
Right arrow Articles by Fung, M.